Taltirelin, the world's first approved oral thyrotropin releasing hormone (TRH), plays certain central nervous system (CNS) effects in addition to endocrine effects, including enhancing motor activity, antagonizing risepin-induced hypothermia, and antagonizing pentobarbital induced sleep (see related literature)
